Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan P van Meerbeeck

Showing results (141-150 of 190) with videos related to

Pageof 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2019
Reply to K. Masuda et alDean A Fennell, Paul Taylor, David Gilligan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 16, 2011
Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesotheliomaKevin Hollevoet, Kristiaan Nackaerts, Robert Gosselin, et al.
The Lancet. Oncology|June 7, 2024
Dendritic cells loaded with allogeneic tumour cell lysate plus best supportive care versus best supportive care alone in patients with pleural mesothelioma as maintenance therapy after chemotherapy (DENIM): a multicentre, open-label, randomised, phase 2/3 studyJoachim G Aerts, Robert Belderbos, Paul Baas, et al.
American Journal of Respiratory Cell and Molecular Biology|February 21, 2004
Proteomic analysis of exosomes isolated from human malignant pleural effusionsMartin P Bard, Joost P Hegmans, Annabrita Hemmes, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 17, 2012
Initial analysis of the international association for the study of lung cancer mesothelioma databaseValerie W Rusch, Dorothy Giroux, Catherine Kennedy, et al.
Journal of Thoracic Disease|April 26, 2019
Diagnostic and clinical features of lung cancer associated with cystic airspacesAnnemie Snoeckx, Pieter Reyntiens, Laurens Carp, et al.
Current Pharmaceutical Biotechnology|May 22, 2014
Impact of microRNAs in resistance to chemotherapy and novel targeted agents in non-small cell lung cancerChristian Rolfo, Daniele Fanale, David S Hong, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 25, 2021
Lung Cancer in BelgiumSebahat Ocak, Kurt Tournoy, Thierry Berghmans, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 3, 2019
Association between surgical volume and post-operative mortality and survival after surgical resection in lung cancer in Belgium: A population-based studyViki Schillemans, France Vrijens, Cindy De Gendt, et al.
Cancer|October 10, 2015
Use of the lung cancer-specific Quality of Life Questionnaire EORTC QLQ-LC13 in clinical trials: A systematic review of the literature 20 years after its developmentMichael Koller, Sophie Warncke, Marianne J Hjermstad, et al.
Pageof 19

Showing results (141-150 of 190) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2019
Reply to K. Masuda et alDean A Fennell, Paul Taylor, David Gilligan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 16, 2011
Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesotheliomaKevin Hollevoet, Kristiaan Nackaerts, Robert Gosselin, et al.
The Lancet. Oncology|June 7, 2024
Dendritic cells loaded with allogeneic tumour cell lysate plus best supportive care versus best supportive care alone in patients with pleural mesothelioma as maintenance therapy after chemotherapy (DENIM): a multicentre, open-label, randomised, phase 2/3 studyJoachim G Aerts, Robert Belderbos, Paul Baas, et al.
American Journal of Respiratory Cell and Molecular Biology|February 21, 2004
Proteomic analysis of exosomes isolated from human malignant pleural effusionsMartin P Bard, Joost P Hegmans, Annabrita Hemmes, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 17, 2012
Initial analysis of the international association for the study of lung cancer mesothelioma databaseValerie W Rusch, Dorothy Giroux, Catherine Kennedy, et al.
Journal of Thoracic Disease|April 26, 2019
Diagnostic and clinical features of lung cancer associated with cystic airspacesAnnemie Snoeckx, Pieter Reyntiens, Laurens Carp, et al.
Current Pharmaceutical Biotechnology|May 22, 2014
Impact of microRNAs in resistance to chemotherapy and novel targeted agents in non-small cell lung cancerChristian Rolfo, Daniele Fanale, David S Hong, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 25, 2021
Lung Cancer in BelgiumSebahat Ocak, Kurt Tournoy, Thierry Berghmans, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 3, 2019
Association between surgical volume and post-operative mortality and survival after surgical resection in lung cancer in Belgium: A population-based studyViki Schillemans, France Vrijens, Cindy De Gendt, et al.
Cancer|October 10, 2015
Use of the lung cancer-specific Quality of Life Questionnaire EORTC QLQ-LC13 in clinical trials: A systematic review of the literature 20 years after its developmentMichael Koller, Sophie Warncke, Marianne J Hjermstad, et al.
Pageof 19